Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus

被引:569
作者
Nakagawa, T
Roth, W
Wong, P
Nelson, A
Farr, A
Deussing, J
Villadangos, JA
Ploegh, H
Peters, C
Rudensky, AY [1 ]
机构
[1] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA
[3] Univ Freiburg Klinikum, Abt Heamatol Onkol, D-79106 Freiburg, Germany
[4] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1126/science.280.5362.450
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Degradation of invariant chain (li) is a critical step in major histocompatibility complex class II-restricted antigen presentation. Cathepsin L was found to be necessary for li degradation in cortical thymic epithelial cells (cTECs), but not in bone marrow (BM)derived antigen-presenting cells (APCs). Consequently, positive selection of CD4(+) T cells, was reduced. Because different cysteine proteinases are responsible for specific li degradation steps in cTECs and BM-derived APCs, the proteolytic environment in cells mediating positive and negative selection may be distinct. The identification of a protease involved in class II presentation in a tissue-specific manner suggests a potential means of manipulating CD4(+) T cell responsiveness in vivo.
引用
收藏
页码:450 / 453
页数:4
相关论文
共 32 条
[1]   NORMAL THYMIC CORTICAL EPITHELIAL-CELLS DEVELOPMENTALLY REGULATE THE EXPRESSION OF A B-LINEAGE TRANSFORMATION-ASSOCIATED ANTIGEN [J].
ADKINS, B ;
TIDMARSH, GF ;
WEISSMAN, IL .
IMMUNOGENETICS, 1988, 27 (03) :180-186
[2]   IN-VIVO AND IN-VITRO FORMATION AND DISSOCIATION OF HLA-DR COMPLEXES WITH INVARIANT CHAIN-DERIVED PEPTIDES [J].
AVVA, RR ;
CRESSWELL, P .
IMMUNITY, 1994, 1 (09) :763-774
[3]   Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L [J].
Bevec, T ;
Stoka, V ;
Pungercic, G ;
Dolenc, I ;
Turk, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1331-1338
[4]   ROLE FOR INTRACELLULAR PROTEASES IN THE PROCESSING AND TRANSPORT OF CLASS-II HLA ANTIGENS [J].
BLUM, JS ;
CRESSWELL, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (11) :3975-3979
[5]   Negative regulation by HLA-DO of MHC class II-restricted antigen processing [J].
Denzin, LK ;
SantAngelo, DB ;
Hammond, C ;
Surman, MJ ;
Cresswell, P .
SCIENCE, 1997, 278 (5335) :106-109
[6]   A study of complexes of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody [J].
Eastman, S ;
Deftos, M ;
DeRoos, PC ;
Hsu, DH ;
Teyton, L ;
Braunstein, NS ;
Hackett, CJ ;
Rudensky, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) :385-393
[7]  
ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.immunol.12.1.181
[8]   Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells [J].
Farr, A ;
DeRoos, PC ;
Eastman, S ;
Rudensky, AY .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (12) :3185-3193
[9]   ISOLATION OF MURINE THYMIC EPITHELIUM AND AN IMPROVED METHOD FOR ITS PROPAGATION INVITRO [J].
FARR, AG ;
EISENHARDT, DJ ;
ANDERSON, SK .
ANATOMICAL RECORD, 1986, 216 (01) :85-94
[10]  
Fineschi B, 1996, J IMMUNOL, V157, P3211